Under the patronage of the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and deputizing for Crown Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime ...
Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback